|
|
![]() |
![]() ![]() |
![]() |
|
||
![]() |
![]() |
Re: Advantage Manocept in advancing therapeutic targeting/treatment over mannose only use full article now available on Biological Function, Regulatory Mechanism, and Clinical
Application of Mannose in Cancer points out 68Ga-DOTA-Manocept (ref 237) as well as Lymphoseek (ref 191) progress along with many others for cancer and other therapeutic. The two main themes in pre proof :
1) Mannose clinical applications and their reported progress on mannose as a therapeutic and as a backbone to transport payloads have been greatly neglected
2) The draft extensively discusses mannose as a therapeutic. In many of the Navidea updates on the development of Manocept, it has been highlighted below that results with a payload attached to the Manocept backbone provide much stronger therapeutic results than mannose backbone alone, The treatment importance and significance of the point that mannose only therapeutics are disadvantaged to Manocept transporting a payload should be a strategic advantage to future funders
|
![]() ![]() ![]() ![]() |
return to message board, top of board |